- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Dyne Therapeutics (DYN)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 575.63 mm | 575.63 mm | 575.63 mm | 575.63 mm | 575.63 mm | 575.63 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 37.96 mm | 37.43 mm | 30.26 mm | 31.31 mm |
| Cash used (since last report) | n/a | n/a | 163.02 mm | 160.72 mm | 129.93 mm | 134.44 mm |
| Cash remaining | n/a | n/a | 412.61 mm | 414.90 mm | 445.69 mm | 441.18 mm |
| Runway (months of cash) | n/a | n/a | 10.9 | 11.1 | 14.7 | 14.1 |
| 13F holders | Current |
|---|---|
| Total holders | 203 |
| Opened positions | 37 |
| Closed positions | 39 |
| Increased positions | 67 |
| Reduced positions | 62 |
| 13F shares | Current |
|---|---|
| Total value | 2.56 tn |
| Total shares | 128.76 mm |
| Total puts | 434.50 k |
| Total calls | 135.10 k |
| Total put/call ratio | 3.2 |
| Largest owners | Shares | Value |
|---|---|---|
| Atlas Venture Life Science Advisors | 8.02 mm | $188.94 bn |
| FMR | 8.00 mm | $188.41 bn |
| BLK BlackRock | 7.95 mm | $187.29 bn |
| JHG Janus Henderson | 7.38 mm | $173.81 bn |
| Vanguard | 6.70 mm | $157.94 bn |
| Ra Capital Management | 6.38 mm | $150.34 bn |
| Capital Fund IV Cooperatief U.A. Forbion | 5.80 mm | $169.23 mm |
| Atlas Venture Fund XI | 5.71 mm | $166.85 mm |
| FCPM Iii Services B.V. | 5.46 mm | $128.70 bn |
| RTW Investments | 5.22 mm | $122.95 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 Dec 25 | Karnani Vikram | Stock option Common Stock | Grant | Acquire A | No | No | 20.78 | 59,665 | 1.24 mm | 59,665 |
| 5 Dec 25 | Douglas Kerr | Common Stock | Sell | Dispose S | No | Yes | 20.72 | 880 | 18.23 k | 87,510 |
| 5 Dec 25 | Johanna Friedl-Naderer | Common Stock | Sell | Dispose S | No | Yes | 20.72 | 144 | 2.98 k | 94,729 |
| 5 Dec 25 | John Cox | Common Stock | Sell | Dispose S | No | No | 20.72 | 2,662 | 55.16 k | 196,877 |